Authors | CADTH [34] | ICER [36] | Jalali [32] | Malone [33] | NCP [37] | Zuluaga-Sanchez [35] |
---|---|---|---|---|---|---|
1. Is the study population clearly described? | 1 | 1 | 1 | 1 | 1 | 1 |
2. Are competing alternatives clearly described? | 1 | 1 | 1 | 1 | 0.5 | 1 |
3. Is a well-defined research question posed in answerable form? | 1 | 1 | 1 | 1 | 1 | 1 |
4. Is the economic study design appropriate to the stated objective? | 1 | 1 | 1 | 1 | 1 | 1 |
5. Is the chosen time horizon appropriate in order to include relevant costs and consequences? | 1 | 1 | 1 | 1 | 1 | 1 |
6. Is the actual perspective chosen appropriate? | 0.5 | 1 | 1 | 0.5 | 1 | 1 |
7. Are all important and relevant costs for each alternative identified? | 0 | 1 | 1 | 1 | 1 | 1 |
8. Are all costs measured appropriately in physical units? | 0 | 1 | 1 | 1 | 0 | 1 |
9. Are costs valued appropriately? | 0 | 0.5 | 1 | 1 | 0 | 1 |
10. Are all important and relevant outcomes for each alternative identified? | 1 | 1 | 1 | 1 | 1 | 1 |
11. Are all outcomes measured appropriately? | 1 | 1 | 1 | 1 | 1 | 1 |
12. Are outcomes valued appropriately? | 1 | 1 | 0 | 1 | 1 | 1 |
13. Is an incremental analysis of costs and outcomes of alternatives performed? | 1 | 1 | 1 | 1 | 1 | 1 |
14. Are all future costs and outcomes discounted appropriately? | 1 | 1 | 0.5 | 0.5 | 0 | 1 |
15. Are all important variables, whose values are uncertain, appropriately subjected to sensitivity analysis? | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
16. Do the conclusions follow from the data reported? | 1 | 1 | 1 | 1 | 1 | 1 |
17. Does the study discuss the generalizability of the results to other settings and patient/client groups? | 0 | 1 | 0 | 0 | 0 | 0.5 |
18. Does the article indicate that there is no potential conflict of interest of study researcher(s) and funder(s)? | 1 | 1 | 1 | 1 | 1 | 1 |
19. Are ethical and distributional issues discussed appropriately? | 0 | 0 | 0.5 | 0 | 0 | 0 |
Total % | 68.4% | 89.5% | 81.6% | 81.6% | 68.4% | 89.5% |